IL1A and Alzheimer disease: Indeed, it has been proposed that the AD pathology can be modulated by innate immune mechanisms associated with infectious burden, including long-term innate memory, which affect epigenetic reprogramming of microglia and the release of IL-1 family cytokines (79, 80).